Efficacy of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Mozambique, 2022

Efficacy of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Mozambique, 2022

Abstract Background Artemether-lumefantrine (AL) and artesunate-amodiaquine (AS-AQ) are the first-line treatments against malaria in Mozambique. Dihydroartemisinin-piperaquine (DP) has been used in-country for mass drug administration campaigns, and artesunate-pyronaridine (AS-PY) is considered an a...

Full description

Saved in:
Bibliographic Details
Main Authors: Abel Nhama, Arlindo Chidimatembue, Lídia Nhamussua, Quique Bassat, Clemente da Silva, Arsénio Nhacolo, Paulo Arnaldo, Crizolgo Salvador, Annette Cassy, Baltazar Candrinho, Mércia Dimene, Eva Carvalho, Abuchahama Saifodine, Flavio Wate, Hélio Mucavele, Yaritbel Torres-Mendoza, Breanna Horton, Mateusz Plucinski, Pau Cistero, Alfredo Mayor, Pedro Aide
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Malaria Journal
Subjects:
Efficacy
Artemether-Lumefantrine
Artesunate-Amodiaquine
Dihydroartemisinin-Piperaquine
Artesunate-Pyronaridine
Uncomplicated malaria
Online Access:https://doi.org/10.1186/s12936-025-05473-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items